Jeffrey Bluestone Gilead Sciences, Inc. (GILD) insider trading activity

Jeffrey Bluestone is Director of GILEAD SCIENCES, INC.. Currently has a direct ownership of 8,920 shares of GILD, which is worth approximately $970,496. The most recent transaction as insider was on Jul 14, 2025, when has been sold 5,000 shares (Common Stock) at a price of $109.74 per share, resulting in proceeds of $548,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.92K

0% 3M change

56.27% 12M change

Total Value Held $970,496

Jeffrey Bluestone Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 14 2025	SELL Open market or private sale	$548,700 $109.74 p/Share	5,000 Reduced 35.92%	8,920 Common Stock
Jul 14 2025	BUY Exercise of conversion of derivative security	$337,250 $67.45 p/Share	5,000 Added 26.43%	13,920 Common Stock
Nov 26 2024	SELL Open market or private sale	$620,355 $91.39 p/Share	6,788 Reduced 43.21%	8,920 Common Stock
Nov 26 2024	BUY Exercise of conversion of derivative security	$612,600 $61.26 p/Share	10,000 Added 38.9%	15,708 Common Stock
May 05 2022	BUY Grant, award, or other acquisition	-	2,444 Added 29.98%	5,708 Common Stock
May 03 2022	BUY Exercise of conversion of derivative security	-	2,223 Added 40.51%	3,264 Common Stock
Dec 08 2021	BUY Exercise of conversion of derivative security	-	1,041 Added 50.0%	1,041 Common Stock

Also insider at

PRVB

Provention Bio, Inc. Healthcare

Director